Ray Jupp

Ray Jupp is the CSO of Mestag Therapeutics. Prior to this Ray was CSO of Enara Bio. Prior to joining Enara Bio, Ray was the founding CSO of TRex Bio, a discovery stage company focused on the functional manipulation of T-regulatory cells in a tissue-specific and disease-specific fashion to deliver transformative therapies for multiple disease indications. Previously, Ray was head of the Immunology/Inflammation therapeutic area at UCB where he drove multiple compounds into development and through phase 1 and 2 trials. Ray has also held research and development leadership roles at Sanofi, Aventis, Rhone-Poulenc Rorer and Roche, where he developed deep expertise in the fields of inflammation, immunology, and infectious disease. Ray graduated with a PhD in Biochemistry from Cardiff University, followed by a post-doctoral fellowship at the Scripps Research Institute, San Diego.